NCT05018637 | Inbo Han|CHA University | Vertebral Compression Fracture|Osteoporotic Fractures | September 1, 2020 | Phase 2 |
NCT02223416 | Gedeon Richter Plc. | Healthy | | Phase 1 |
NCT00557310 | Eli Lilly and Company | Osteoporosis, Postmenopausal | November 2007 | Phase 4 |
NCT01473602 | Eli Lilly and Company | Femur Neck Fracture | January 2012 | Phase 3 |
NCT03994172 | VA Office of Research and Development|University of California, San Francisco | Male Osteoporosis | July 1, 2019 | Phase 4 |
NCT03692143 | Nanfang Hospital, Southern Medical University | Osteoporosis, Postmenopausal|Vertebral Fracture|Quality of Life | January 1, 2017 | |
NCT04473989 | Peking University Third Hospital | Colles´ Fracture | June 1, 2021 | Phase 2 |
NCT01679080 | University of Aarhus | Osteogenesis Imperfecta | November 2012 | Phase 2 |
NCT00542984 | Eli Lilly and Company | Osteoporosis, Postmenopausal | August 2003 | Phase 3 |
NCT04206618 | 424 General Military Hospital|Beth Israel Deaconess Medical Center | Osteoporosis, Postmenopausal | June 1, 2019 | |
NCT00927186 | Eli Lilly and Company | Osteoporosis, Post-menopausal | July 2009 | Phase 4 |
NCT01166958 | University of Wisconsin, Madison | Osteoporosis | September 2010 | Phase 4 |
NCT00577863 | Eli Lilly and Company | Osteoporosis | January 2008 | Phase 3 |
NCT01173081 | Ohio Orthopedic Center of Excellence|Eli Lilly and Company | Fractures | July 2010 | Phase 4 |
NCT01611571 | Columbia University|Alliance for Better Bone Health | Osteoporosis | December 2003 | Phase 3 |
NCT00191425 | Eli Lilly and Company | Osteoporosis, Postmenopausal | August 2002 | Phase 4 |
NCT04974723 | Radius Health, Inc.|PRA Health Sciences | Osteoporosis, Postmenopausal | July 1, 2021 | |
NCT02176382 | Massachusetts General Hospital | Postmenopausal Osteoporosis | August 2014 | Phase 4 |
NCT00887354 | Eli Lilly and Company | Osteoporosis | April 2009 | Phase 4 |
NCT00433160 | Eli Lilly and Company | Osteoporosis | January 2007 | Phase 3 |
NCT01705587 | Susan L. Greenspan|University of Pittsburgh|Eli Lilly and Company | Osteoporosis|Atypical Femoral Fracture | December 2012 | Phase 4 |
NCT04879420 | Brigham and Women´s Hospital | Osteoporosis | October 29, 2020 | |
NCT01734824 | Medical University of Vienna | Bone Marrow Oedema Syndrome|High Turnover Bone Disease|Quality of Life | May 2012 | Phase 4 |
NCT00624481 | Nastech Pharmaceutical Company, Inc. | Osteopenia|Osteoporosis | March 2008 | Phase 2 |
NCT01011556 | Eli Lilly and Company|TransPharma Medical | Osteoporosis | November 2009 | Phase 2 |
NCT00191802 | Eli Lilly and Company | Osteoporosis | September 2003 | Phase 3 |
NCT03002428 | Pfenex, Inc | Osteoporosis | December 2016 | Phase 3 |
NCT04196855 | University of East Anglia|Ministry of Defence, United Kingdom|Darlington Memorial Hospital|Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK) | Stress Fracture|Parathyroid Hormone | December 23, 2019 | Phase 3 |
NCT01153425 | University of Pennsylvania|Eli Lilly and Company|Novartis Pharmaceuticals|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Osteoporosis, Osteopenia | July 2008 | Phase 4 |
NCT01171690 | Mayo Clinic | Hypoparathyroidism Post-surgical | November 2010 | Phase 2 |
NCT03770338 | The University of Hong Kong | Osteoporosis|Fusion of Spine, Lumbar Region | March 1, 2019 | Not Applicable |
NCT00131469 | Oregon Health and Science University|Eli Lilly and Company|Osteogenesis Imperfecta Foundation|National Institutes of Health (NIH)|National Center for Research Resources (NCRR) | Osteogenesis Imperfecta | June 2005 | Phase 4 |
NCT00594906 | University of Rochester|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|National Institutes of Health (NIH) | Pelvic Fracture | January 2008 | Not Applicable |
NCT01709110 | Eli Lilly and Company | Postmenopausal Osteoporosis | October 2012 | Phase 4 |
NCT01896011 | University Health Network, Toronto|The Physicians´ Services Incorporated Foundation|Eli Lilly and Company | Non Displaced Atypical Femoral Fractures | July 2013 | Phase 3 |
NCT01279187 | University of Michigan|Eli Lilly and Company | Implant | February 2011 | Phase 2 |
NCT00065637 | University of California, San Francisco|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Osteopenia|Osteoporosis | December 2003 | Phase 3 |
NCT01321723 | Unigene Laboratories Inc.|GlaxoSmithKline | Postmenopausal Osteoporosis | February 2011 | Phase 2 |
NCT00696644 | Eli Lilly and Company | Osteoporosis, Postmenopausal|Osteoporosis | June 2008 | |
NCT00471237 | GlaxoSmithKline | Osteoporosis | May 14, 2007 | Phase 2 |
NCT03720886 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Postmenopausal Osteoporosis | October 1, 2018 | Phase 1|Phase 2 |
NCT01750086 | Massachusetts General Hospital | Postmenopausal Osteoporosis | January 2013 | Phase 4 |
NCT01535027 | Medical University of Vienna | Osteoporosis | March 2006 | Phase 4 |
NCT02824718 | Assistance Publique - Hôpitaux de Paris|Ministry of Health, France | Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment | June 6, 2017 | Phase 2 |
NCT00414973 | Eli Lilly and Company | Osteoporosis | December 2006 | Phase 3 |
NCT01155232 | University Health Network, Toronto | Osteoporosis | November 2004 | |
NCT05866029 | Peking Union Medical College Hospital | Osteoporotic Fractures | June 2, 2023 | Not Applicable |
NCT01760798 | Postgraduate Institute of Medical Education and Research | Osteoporosis | January 2012 | Not Applicable |
NCT00668941 | Helen Hayes Hospital|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Health Research, Inc. | Osteoporosis | September 2005 | Phase 2 |
NCT02656810 | Pfenex, Inc | Osteoporosis | December 2015 | Phase 1 |
NCT00446589 | Papageorgiou General Hospital | Osteoporosis | July 2006 | Phase 4 |
NCT00896532 | Amgen | Low Bone Mineral Density|Postmenopausal Osteoporosis | June 3, 2009 | Phase 2 |
NCT01400516 | Brigham and Women´s Hospital|Eli Lilly and Company | Rheumatoid Arthritis | August 2011 | Phase 4 |
NCT01292252 | Shane Burch|Eli Lilly and Company|University of California, San Francisco | Lumbar Spondylosis|Lumbar Spondylolisthesis|Adult Degenerative Lumbar Scoliosis | August 2011 | Phase 4 |
NCT00191321 | Eli Lilly and Company | Osteoporosis | July 2004 | Phase 3 |
NCT02091492 | Medical University of Vienna | Osteoporosis, Age-Related|Humeral Fractures | June 2014 | Phase 3 |
NCT01796301 | Amgen | Postmenopausal Osteoporosis | January 31, 2013 | Phase 3 |
NCT00926380 | Massachusetts General Hospital|Amgen | Osteoporosis | June 2009 | Phase 2 |
NCT01945788 | Bio Sidus SA | Postmenopausal Osteoporosis With Pathological Fracture | June 2013 | Phase 4 |
NCT00079924 | Eli Lilly and Company | Postmenopausal Osteoporosis | November 2004 | Phase 4 |
NCT04522622 | Ditte Hansen|Odense University Hospital|Steno Diabetes Center Copenhagen|Rigshospitalet, Denmark|Aalborg University Hospital|Herlev Hospital | Adynamic Bone Disease|Chronic Kidney Diseases|Cardiac Disease|Chronic Kidney Disease-Mineral and Bone Disorder | December 15, 2021 | Phase 4 |
NCT00754442 | University of Maryland, Baltimore | Secondary Hyperparathyroidism | February 2007 | Not Applicable |
NCT01293292 | Sheffield Teaching Hospitals NHS Foundation Trust | Osteoporosis | January 2011 | Phase 4 |
NCT00191867 | Eli Lilly and Company | Osteoporosis | February 2005 | Phase 2 |
NCT00035256 | Eli Lilly and Company | Osteoporosis, Postmenopausal | October 2001 | Phase 4 |
NCT02563353 | Odense University Hospital|University of Southern Denmark|Copenhagen University Hospital, Denmark|Hospital of South West Jutland|Sygehus Lillebaelt|Odense Patient Data Explorative Network|Region of Southern Denmark | Osteoporosis | November 2015 | Not Applicable |
NCT01343004 | Radius Health, Inc. | Osteoporosis|Postmenopausal Osteoporosis | April 2011 | Phase 3 |
NCT03735537 | University of Edinburgh|NHS Lothian | Osteogenesis Imperfecta | November 1, 2016 | Phase 4 |
NCT00532545 | Eli Lilly and Company | Osteoporosis, Post-Menopausal | April 2003 | Phase 4 |
NCT05151484 | Hartmut Malluche, MD|National Institute on Aging (NIA)|University of Kentucky | Age-Related Osteoporosis | March 21, 2022 | Phase 4 |
NCT00759772 | Massachusetts General Hospital|Eli Lilly and Company | Anorexia Nervosa|Osteoporosis | September 2008 | Phase 2 |
NCT01440803 | Elizabeth Shane|Food and Drug Administration (FDA)|Columbia University | Adult Idiopathic Generalized Osteoporosis | August 2, 2012 | Phase 2 |
NCT00697463 | Columbia University|Eli Lilly and Company | Menopause|Fracture|Osteoporosis | August 20, 2008 | Phase 2|Phase 3 |
NCT00535860 | TransPharma Medical|Eli Lilly and Company | Osteoporosis | April 2008 | Phase 2 |
NCT03472846 | Medical University of Vienna|St. Vincent Hospital, Vienna | Postmenopausal Osteoporosis|Diabetes Type 2 | March 1, 2017 | Phase 4 |
NCT00542425 | Radius Health, Inc. | Osteoporosis | April 2007 | Phase 2 |
NCT01309399 | Health Research, Inc.|Hospital for Special Surgery, New York|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Osteoporosis | August 2010 | Not Applicable |
NCT00051558 | Eli Lilly and Company | Osteoporosis | November 2002 | Phase 3 |
NCT00347737 | Leland Graves III, MD|University of Kansas|University of Kansas Medical Center | Osteoporosis | June 2006 | Not Applicable |
NCT01105832 | University Hospital, Linkoeping | Humeral Fracture | April 2010 | Phase 4 |
NCT00343252 | Eli Lilly and Company | Osteoporosis, Postmenopausal|Back Pain|Spinal Fracture | June 2006 | Phase 3 |
NCT02972424 | Hospital for Special Surgery, New York|Weill Medical College of Cornell University | Osteoporotic Fractures | May 1, 2017 | Phase 2 |
NCT02416271 | Eli Lilly and Company | Osteoporosis | April 2001 | Phase 4 |
NCT02023411 | Postgraduate Institute of Medical Education and Research | Diabetic Neuropathic Arthropathy | January 2014 | Phase 2 |
NCT00670501 | Eli Lilly and Company | Osteoporosis, Postmenopausal | August 1996 | Phase 3 |
NCT00532207 | Eli Lilly and Company | Osteoporosis, Post-Menopausal | November 2003 | Phase 3 |
NCT00503399 | Eli Lilly and Company | Osteoporosis | July 2007 | Phase 3 |
NCT00623974 | M.D. Anderson Cancer Center|Eli Lilly and Company | Hypocalcemia | May 2008 | Phase 2 |
NCT01360424 | Helsinki University Central Hospital|Eli Lilly and Company | Osteoporosis | May 2011 | Phase 4 |
NCT04669782 | University of Milano Bicocca | Bone Metabolism Disorder|Aging Disorder|Osteoporosis | November 24, 2020 | Not Applicable |
NCT02571140 | Entera Bio Ltd. | Drug Safety and Bioavailability | October 2013 | Phase 1 |
NCT00543218 | Eli Lilly and Company | Osteoporosis, Post-Menopausal | December 2002 | Phase 3 |
NCT00761332 | Eli Lilly and Company | Osteoporosis | February 2008 | |
NCT00439244 | Novartis | Osteoporosis | December 2006 | Phase 3 |
NCT02156960 | Shinshu University | Osteoporosis | May 2014 | Phase 4 |
NCT00393380 | The Emmes Company, LLC|National Heart, Lung, and Blood Institute (NHLBI) | Leukemia, Myeloid, Chronic|Anemia, Aplastic|Myelofibrosis|Lymphoma|Hodgkin Disease|Leukemia, Lymphocytic, Chronic|Leukemia, Myelocytic, Acute|Leukemia, Lymphocytic, Acute | September 2006 | Phase 2 |
NCT04921124 | Norfolk and Norwich University Hospitals NHS Foundation Trust|University of East Anglia|Ministry of Defence, United Kingdom | Stress Fracture | May 24, 2021 | Phase 3 |
NCT00046137 | Eli Lilly and Company | Osteoporosis, Postmenopausal | | Phase 3 |
NCT03133195 | King Chulalongkorn Memorial Hospital | Unstable Intertrochanteric Fracture | May 17, 2017 | Phase 3 |
NCT00259298 | Eli Lilly and Company | Osteoporosis | November 2005 | Phase 4 |
NCT02202603 | Entera Bio Ltd. | Drug Safety | July 2011 | Phase 1 |
NCT01473589 | Eli Lilly and Company | Femur Neck Fracture | February 2012 | Phase 3 |
NCT00190944 | Eli Lilly and Company | Colles´ Fracture | December 2004 | Phase 2 |
NCT02090244 | University Hospital, Linkoeping|Medical Research Council of Southeast Sweden | Spinal Stenosis | August 2012 | Phase 4 |
NCT00826228 | Thomas J. Schnitzer|Eli Lilly and Company|Shirley Ryan AbilityLab|Northwestern University | Osteoporosis|Bone Loss|Spinal Cord Injury | June 2009 | Phase 4 |
NCT01430104 | Eli Lilly and Company | Osteoporosis | August 2011 | Phase 4 |
NCT02472782 | 251 Hellenic Air Force & VA General Hospital|Hellenic Osteoporosis Foundation (www.http:++heliost.gr+en+) | Osteoporosis, Postmenopausal|Osteoporosis, Steroid Induced | May 2015 | |
NCT00005006 | Helen Hayes Hospital|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Osteoporosis | September 1987 | Phase 2 |
NCT04750460 | Saint Petersburg State University, Russia | Secondary Hyperparathyroidism|Chronic Kidney Disease-Mineral and Bone Disorder|Dialysis|Hypocalcemia|Hypoparathyroidism | March 1, 2021 | Phase 3 |
NCT01063504 | University Hospital, Linkoeping | Osteoarthritis of the Knee | February 2010 | Phase 2 |
NCT01753856 | Eli Lilly and Company | Osteoporosis | January 2013 | Phase 4 |
NCT02440581 | Hartmut Malluche, MD|Wright State University|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University of Kentucky | Kidney Failure, Chronic | July 1, 2015 | Not Applicable |
NCT01225055 | Thomas J. Schnitzer|Edward Hines Jr. VA Hospital|University of Illinois at Chicago|Northwestern University | Spinal Cord Injury|Bone Loss|Osteoporosis | October 2010 | Phase 2 |
NCT00191893 | Eli Lilly and Company | Osteoporosis | September 2003 | Phase 3 |
NCT02025179 | Northwestern University|United States Department of Defense | Spinal Cord Injury|Bone Loss|Osteoporosis | January 2013 | Phase 2 |
NCT04026256 | Massachusetts General Hospital|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Postmenopausal Osteoporosis | September 2, 2019 | Phase 4 |
NCT01604057 | Azelon Pharmaceuticals | Osteoporosis|Osteopenia | November 2011 | Phase 2 |
NCT03072147 | Christopher Ritchlin|Eli Lilly and Company|University of Rochester|Duke University|Milton S. Hershey Medical Center | Knee Osteoarthritis|Cartilage Degeneration | May 1, 2017 | Phase 2 |
NCT04589819 | University of South Carolina|United States Department of Defense|Eisenhower Army Medical Center|Moncrief Army Health Clinic | Stress Fracture of Tibia or Fibula | December 8, 2022 | Phase 4 |
NCT00239629 | Eli Lilly and Company | Postmenopausal Osteoporosis | September 2005 | Phase 4 |